Centers for Disease Control and Prevention, Division of Viral Hepatitis, Atlanta, Georgia, USA.
Ann Intern Med. 2012 Dec 4;157(11):817-22. doi: 10.7326/0003-4819-157-9-201211060-00529.
The Centers for Disease Control and Prevention (CDC) and a group of governmental and private sector partners developed these evidence-based recommendations to increase the proportion of hepatitis C virus (HCV)-infected persons who know their status and are linked to appropriate care and treatment. The recommendations also address brief alcohol screening, as alcohol accelerates progression of liver disease among HCV-infected individuals. These recommendations augment CDC's 1998 and 1999 recommendations based on risk and medical indications and are not meant to replace those recommendations.
These recommendations are based on systematic reviews of evidence published from 1995 through February 2012 in MEDLINE, EMBASE, CINAHL, the Cochrane Central Register of Controlled Trials, Sociological Abstracts, and Database of Abstracts of Reviews of Effects. Selected studies included cross-sectional and cohort studies that addressed either prevalence of hepatitis C in the United States or clinical outcomes (for example, hepatocellular carcinoma and serious adverse events) among treated patients and systematic reviews of trials that assessed effectiveness of brief screening interventions for alcohol consumption. The Grading of Recommendations Assessment, Development, and Evaluation framework was used to assess quality of the evidence. RECOMMENDATION 1: Adults born during 1945-1965 should receive 1-time testing for HCV without prior ascertainment of HCV risk. (Grade: strong recommendation; moderate-quality evidence). RECOMMENDATION 2: All persons with identified HCV infection should receive a brief alcohol screening and intervention as clinically indicated, followed by referral to appropriate care and treatment services for HCV infection and related conditions (Grade: strong recommendation; moderate-quality evidence).
疾病控制与预防中心(CDC)和一组政府和私营部门合作伙伴制定了这些基于证据的建议,以增加已知 HCV 感染状况并与适当护理和治疗相联系的 HCV 感染者的比例。这些建议还涉及简短的酒精筛查,因为酒精会加速 HCV 感染者的肝病进展。这些建议补充了 CDC 1998 年和 1999 年基于风险和医学指征的建议,并非旨在取代这些建议。
这些建议是基于对 1995 年至 2012 年 2 月在 MEDLINE、EMBASE、CINAHL、 Cochrane 中央对照试验注册、社会学摘要和效果摘要数据库中发表的证据进行系统审查得出的。选定的研究包括横断面和队列研究,这些研究涉及美国 HCV 的流行情况或治疗患者的临床结果(例如肝细胞癌和严重不良事件),以及评估简短酒精筛查干预措施对酒精消费有效性的试验系统评价。使用推荐评估、制定和评估框架对证据质量进行评估。建议 1:应在没有事先确定 HCV 风险的情况下,对 1945 年至 1965 年出生的成年人进行 1 次 HCV 检测。(强烈推荐;中等质量证据)。建议 2:所有已确定 HCV 感染的人都应根据临床需要进行简短的酒精筛查和干预,然后转介到适当的 HCV 感染和相关疾病护理和治疗服务(强烈推荐;中等质量证据)。